drugset / Trial / NCT01453738

Allogeneic Mesenchymal Stem Cells in Osteoarthritis

NCT01453738

Phase 2 Completed 60 enrolled Stempeutics Research Pvt Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial is planed to study if allogeneic mesenchymal stem cells would be safe and beneficial in osteoarthritis of knee joint. This is a double blind study. Different doses of stem cells will be used in this study.

Timeline

Start
2011-11
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Stempeucel® Cell therapy 25 cells Other
Subject Stempeucel® Cell therapy 50 cells Other
Subject Stempeucel® Cell therapy 75 cells Other
Subject Stempeucel® Cell therapy 150 cells Other
Background Hyaluronic Acid Other / unclassified 2 ml Other

Indications